- New Chinese distribution partner for two of the group’s leading oral care brands – Dentyl and UltraDEX
- Directors purchased 300,000 shares at the end of 2021
- BBI Healthcare and Helsinn starting to make progress on exploring and exploiting the expected synergies
Aim-traded Venture Life (VLG:40p), a developer, manufacturer and distributor of products for the self-care markets, has appointed a new Chinese partner for two of the group’s leading oral care brands – Dentyl and UltraDEX – both of which have established recognition and sales in the China market.
Venture’s previous Chinese partner failed to deliver on its minimum contractual sales targets, so the appointment of UK-based Samarkand is a smart move. The publicly listed group has proven expertise in connecting UK brands to the Chinese consumer, representing large brands such as Omorovicza, Temple Spa and Philip Kingsley.